ARQT Earnings Arcutis Biotherapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.09 | 2026-05-06 | 10-Q |
| FY 2025 | 2025-12-31 | -0.13 | 2026-02-25 | 10-K |
| Q3 2025 | 2025-09-30 | -0.26 | 2025-10-28 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.32 | 2025-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.20 | 2026-05-06 | 10-Q |
| FY 2025 | 2024-12-31 | -1.16 | 2026-02-25 | 10-K |
| Q3 2025 | 2024-09-30 | -1.08 | 2025-10-28 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.75 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.32 | 2025-05-06 | 10-Q |
| FY 2025 | 2023-12-31 | -3.78 | 2026-02-25 | 10-K |
| Q3 2024 | 2023-09-30 | -3.19 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -2.46 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.31 | 2024-05-14 | 10-Q |
| FY 2024 | 2022-12-31 | -5.66 | 2025-02-25 | 10-K |
| Q3 2023 | 2022-09-30 | -4.52 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | -2.58 | 2023-08-08 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.27 | 2023-05-09 | 10-Q |
| FY 2023 | 2021-12-31 | -4.18 | 2024-02-27 | 10-K |
| Q3 2022 | 2021-09-30 | -2.75 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.60 | 2022-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.